6.17
+0.11(+1.82%)
Currency In USD
| Previous Close | 6.06 |
| Open | 6.23 |
| Day High | 6.23 |
| Day Low | 6.17 |
| 52-Week High | 7.6 |
| 52-Week Low | 3.38 |
| Volume | 3,073 |
| Average Volume | 14,471 |
| Market Cap | 55.81M |
| PE | 29.38 |
| EPS | 0.21 |
| Moving Average 50 Days | 6.27 |
| Moving Average 200 Days | 5.82 |
| Change | 0.11 |
If you invested $1000 in ImmuCell Corporation (ICCC) 10 years ago, it would be worth $907.35 as of October 20, 2025 at a share price of $6.17. Whereas If you bought $1000 worth of ImmuCell Corporation (ICCC) shares 5 years ago, it would be worth $1,040.47 as of October 20, 2025 at a share price of $6.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
GlobeNewswire Inc.
Oct 07, 2025 8:05 PM GMT
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve
ImmuCell Announces Selection of its Next President and CEO
GlobeNewswire Inc.
Sep 29, 2025 8:05 PM GMT
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve
ImmuCell Announces Bank Debt Refinancing
GlobeNewswire Inc.
Aug 12, 2025 8:05 PM GMT
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve